Weight-related comorbidities are health conditions that develop or worsen as a direct consequence of carrying excess body weight. They span nearly every organ system, from the heart and liver to the joints and reproductive organs. At least 13 types of cancer, several cardiovascular diseases, type 2 diabetes, sleep apnea, fatty liver disease, and depression all have well-established links to overweight and obesity.
How Excess Weight Triggers Disease
Fat tissue is not passive storage. It behaves like an active organ, releasing signaling molecules that promote chronic, low-grade inflammation throughout the body. This persistent inflammation damages blood vessel walls, disrupts how your cells respond to insulin, alters hormone levels, and creates an environment where many diseases take root. Visceral fat, the deep fat packed around your abdominal organs, is especially harmful because it drains inflammatory compounds directly into the liver via the portal vein, amplifying the damage.
Waist circumference is one practical way to gauge visceral fat risk. For white adults, a waist measurement above 102 cm (about 40 inches) in men or above 88 cm (about 35 inches) in women signals elevated metabolic danger. More refined thresholds exist within each BMI category: for instance, a normal-weight woman with a waist of 80 cm or more, or a normal-weight man at 90 cm or more, already faces increased health risk compared to peers with smaller waists.
Type 2 Diabetes and Insulin Resistance
Insulin resistance is one of the earliest and most consequential metabolic shifts caused by excess weight. Normally, insulin tells your cells to absorb sugar from the blood. In obesity, inflammatory molecules from fat tissue interfere with that signal, forcing the pancreas to produce more and more insulin to get the same effect. Eventually the pancreas can’t keep up, blood sugar stays elevated, and type 2 diabetes develops.
Several mechanisms drive this process simultaneously. Saturated fatty acids and excess glucose activate immune receptors in fat and liver tissue, recruiting immune cells that release even more inflammatory compounds. Changes in gut bacteria composition add another layer, further stimulating those same immune pathways. The result is a self-reinforcing cycle: more fat tissue creates more inflammation, which worsens insulin resistance, which promotes further fat accumulation.
Cardiovascular Disease
Obesity is a major risk factor for atherosclerosis, the buildup of fatty plaques inside artery walls. The signaling molecules released by excess fat tissue cause the inner lining of blood vessels to malfunction, allowing cholesterol and immune cells to infiltrate the artery wall. Over time this leads to narrowed arteries, reduced blood flow, and a higher likelihood of blood clots.
The downstream consequences include coronary heart disease, heart attack, and heart failure. Obesity also raises levels of a hormone called aldosterone, which promotes high blood pressure by causing the body to retain sodium and water. The combination of stiff, narrowed arteries and elevated blood pressure forces the heart to work harder with every beat, gradually weakening the muscle.
Sleep Apnea
Obstructive sleep apnea, where the airway repeatedly collapses during sleep, is dramatically more common in people with obesity. In the general population, roughly 3 to 7 percent of men and 2 to 5 percent of women have it. Among people with severe obesity undergoing bariatric surgery, the prevalence reaches 77 percent. Excess fat around the neck and throat physically compresses the airway, while abdominal fat reduces lung volume, making each breathing interruption more severe. Left untreated, sleep apnea raises the risk of high blood pressure, heart disease, and daytime fatigue that impairs daily functioning.
Fatty Liver Disease
When fat accumulates inside liver cells, it causes a condition now called metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. Data from U.S. adolescents between 2017 and 2020 found that about 70 percent of those with obesity had MASLD. In some people the fat deposits trigger ongoing liver inflammation, which can progress to scarring and, in severe cases, liver failure. Because the liver processes fats, sugars, and toxins for the entire body, its impairment accelerates many of the other comorbidities on this list.
Gallstones
Excess abdominal fat increases insulin levels, and higher insulin stimulates the liver to produce more cholesterol. That cholesterol gets secreted into bile, the digestive fluid stored in the gallbladder. When bile becomes oversaturated with cholesterol, solid crystals form and eventually grow into gallstones. This is why rapid weight loss can also trigger gallstones: the liver dumps even more cholesterol into bile during fast fat breakdown, temporarily worsening the imbalance.
Joint Damage and Osteoarthritis
Every extra kilogram of body weight adds roughly two to four kilograms of force across the knee with each step. Population-level data shows that for every one-unit increase in BMI, the risk of knee osteoarthritis rises by about 9 percent. Hip osteoarthritis risk increases by roughly 4 percent per BMI unit, and even hand osteoarthritis, a joint that bears no body weight, goes up by about 2 percent per unit. That last finding points to something beyond mechanical stress: the same inflammatory molecules produced by excess fat tissue also break down cartilage directly, which is why weight-related joint damage isn’t limited to weight-bearing joints.
13 Types of Cancer
The CDC identifies 13 cancers associated with overweight and obesity:
- Esophageal adenocarcinoma
- Postmenopausal breast cancer
- Colon and rectal cancer
- Uterine cancer
- Gallbladder cancer
- Upper stomach cancer
- Kidney cancer
- Liver cancer
- Ovarian cancer
- Pancreatic cancer
- Thyroid cancer
- Meningioma (a type of brain tumor)
- Multiple myeloma (a blood cancer)
The connecting threads are chronic inflammation, elevated insulin levels, and higher circulating levels of estrogen produced by fat tissue. Each of these factors can promote cell growth and suppress the body’s ability to destroy abnormal cells before they become cancerous.
Depression and Anxiety
The relationship between obesity and depression runs in both directions. A meta-analysis of 19 studies found that people with depression had a 37 percent increased risk of becoming obese, while people with obesity had an 18 percent increased risk of developing depression. A separate review focused on sex differences found that people with obesity were 32 percent more likely to have depression overall, but the disparity was far greater in women (36 percent increased risk) than in men (8 percent).
Biologically, the same inflammatory compounds that damage blood vessels and impair insulin signaling also cross into the brain and alter neurotransmitter function. Socially, weight stigma, reduced mobility, and chronic pain from other comorbidities create additional psychological burden. About 24 percent of women and 21 percent of men with obesity meet criteria for clinical depression, rates that are notably higher than in the normal-weight population.
Reproductive Health
In men, excess fat tissue converts testosterone into estrogen through a process called aromatization. The rise in estrogen signals the brain to reduce production of the hormones that stimulate the testes, lowering testosterone further. This creates another vicious cycle: lower testosterone promotes more fat storage, which drives testosterone even lower. Studies consistently show a direct negative correlation between BMI and total testosterone levels. Inflammatory markers elevated in obesity compound the problem, and sperm quality often suffers as a result.
In women, excess weight is closely tied to polycystic ovary syndrome (PCOS), a condition involving irregular ovulation, elevated levels of male hormones, and insulin resistance. The insulin resistance driven by obesity worsens PCOS symptoms, making ovulation less predictable and reducing fertility. Weight loss before attempting conception improves outcomes for both sexes.
How These Conditions Overlap
Weight-related comorbidities rarely appear in isolation. Insulin resistance raises blood pressure and worsens cholesterol, accelerating atherosclerosis. Sleep apnea disrupts sleep quality, which increases cortisol and appetite, promoting further weight gain. Depression reduces motivation to exercise and can lead to emotional eating. Fatty liver disease amplifies insulin resistance, feeding back into diabetes risk. This interconnected web is why even modest weight reduction, on the order of 5 to 10 percent of body weight, can produce measurable improvements across multiple conditions simultaneously. Losing that weight reduces inflammatory signaling at its source, easing the burden on nearly every affected system at once.